http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1153071-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
| filingDate | 1966-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1969-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1153071-A |
| titleOfInvention | Process for the preparation of New Therapeutically Active Basic Ethers |
| abstract | 1,153,071. Basic ethers. EGYESULT GYOGYSZER ES TAPSZERGYAR. 9 Aug., 1966 [12 Aug., 1965], No. 35681/66. Heading C2C. Novel compounds I of Formula I, in which R is C 4-15 alkyl, C 4-7 cycloalkyl or C 4-7 cycloalkyl- C 1-3 alkyl, A is C 1-4 alkylene, Z is di(C 1-3 alkyl)- amino and n is 2 to 8, and acid addition salts and quaternary ammonium derivatives thereof, are prepared by (a) reacting a compound II of Formula II, or a metal derivative thereof, with a compound of formula Hal-A-Y, in which Hal is halogen and Y is hydroxy or halogen or has the same meaning as Z, or (b) reacting a reactive ester of a compound II with a compound of formula HO-A-Y, if necessary, converting the atom or group Y in the product obtained into the desired group Z by known methods and, if desired converting a compound I into an acid addition salt or quaternary ammonium derivative. Compounds I are stated to have spasmolytic, minor tranquillizing, local anaesthetic and ulcer-inhibiting effects. |
| priorityDate | 1965-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564 |
Total number of triples: 15.